FDA
approval
· 2017-05-26
FDA Approved: BETASERON — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)
Summary
FDA approved a supplemental application for Betaseron (interferon beta-1b) submitted by Bayer HealthCare Pharmaceuticals Inc.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for BETASERON (INTERFERON BETA-1B)